Tower Research Capital (TRC)’s Viemed Healthcare VMD Stock Holding History
Bought
Maintained
Sold
Other funds holding VMD
Tower Research Capital (TRC)'s VMD Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Viemed Healthcare (VMD) stake by 55% in Q3 2026, selling an estimated $16.4K and leaving 1,351 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4144.
Tower Research Capital (TRC) first reported a position in VMD in Q2 2020 and has held it in 26 quarters since. The position peaked at $321K in Q3 2020. 169 funds tracked by Wall St. Rank hold VMD as of Q3 2026.
- Tower Research Capital (TRC) held 1,351 shares of Viemed Healthcare worth $12.3K as of Q3 2026.
- Tower Research Capital (TRC) sold 1,629 Viemed Healthcare shares in Q3 2026, an estimated $16.4K.
- Viemed Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4144 holding.
- Tower Research Capital (TRC) first reported a position in Viemed Healthcare in Q2 2020 and has held it in 26 quarters since.
- Tower Research Capital (TRC)'s Viemed Healthcare position peaked at $321K in Q3 2020.
- 169 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.